Liberia’s fight against monkeypox received a major boost last week as Chargé d’Affaires Joe Zadrozny formally handed over more than 40,000 vaccine doses to the Government of Liberia, marking a significant milestone in U.S.–Liberia health cooperation.The U.S.-supported delivery comes at a critical time, with rising monkeypox cases reported in hotspot communities.
The vaccines are expected to strengthen Liberia’s ability to respond swiftly to outbreaks, protect contacts of confirmed cases, and safeguard at-risk populations.Technical support for the shipment was provided by the U.S. Centers for Disease Control and Prevention (CDC), working in close collaboration with Liberia’s Ministry of Health and the National Public Health Institute of Liberia (NPHIL).Speaking at the handover, Zadrozny emphasized America’s commitment to global health security:
“Strong public health systems save lives, promote stability, and make both our countries safer. By helping partners stop outbreaks at their source, we protect Americans at home and abroad.”Liberia’s health professionals and frontline workers were commended for their leadership in tackling the outbreak.
The partnership underscores a shared commitment to accountability, results-driven cooperation, and advancing health security.The donation highlights the broader U.S.–Liberia collaboration in public health, reinforcing efforts to build resilience against infectious diseases and safeguard communities across the nation.
